The Abdominal Aorta

Published on 13/02/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3418 times

CHAPTER 102 The Abdominal Aorta

TECHNIQUES

The choice of imaging technique used to evaluate the aorta is determined by patient and disease-specific indications. Plain radiography has a limited role except following endovascular stent graft placement. Ultrasound has been shown to be an effective screening tool and has the advantages of portability, price, absence of ionizing radiation, or potentially nephrotoxic contrast. MDCT has much greater spatial resolution than any other cross-sectional modality and offers the added advantage of clear demonstration of visceral organs and extremely rapid image acquisition. Magnetic resonance imaging (MRI) techniques can provide additional physiologic information such as flow quantification. There is increasing evidence that PET-CT may be useful in the evaluation of the inflammatory and the noninflammatory aortic aneurysm.

CT Techniques

With recent advances in MDCT technology, routine acquisition of a high resolution isotropic volumetric dataset at the peak of contrast enhancement is easily achieved. There are several advantages to MDCT, but perhaps the greatest is the ability to analyze and display the aorta and branch vessels in any plane and to perform three-dimensional volume rendering for improved visualization and vascular diagnosis.

Using MDCT, a helical volume is acquired with a detector collimation of between 0.5 and 1.5 mm, and reconstructed with a similar thickness using a matrix size of 512 × 512 or greater. The use of tube current modulation techniques (e.g., automated exposure control) reduces radiation exposure compared to fixed-tube current techniques. For MDCT angiography, increased vascular enhancement can be achieved by reducing the kVp to 100 keV (or 80 keV in smaller patients) because this increases photon attenuation by iodinated contrast and moves the mean energy closer to the k-edge of iodine (33.2).1

Prior to acquisition of the arterial phase images, a noncontrast CT image set can be obtained. This is particularly useful where significant vascular calcification is expected, or in instances in which intramural hematoma is a differential consideration. Proper timing of the CTA volume acquisition with peak arterial contrast enhancement is critical for optimal arterial illustrations. For detection of associated parenchymal abnormalities, scar tissue, and endoleaks, the addition of delayed phase images can also be helpful. If multiple phases are used routinely, acquisition of those additional phases using lower radiation dose techniques should be considered to minimize patient radiation exposure doses.

After the patient is scanned, the dataset can be sent to a postprocessing workstation for both two-dimensional and three-dimensional image reconstruction, and for evaluation of the aorta and branch vessels in a double-oblique true axial plane.

MRI Techniques

Coils and Patient Position

Patients are imaged supine, ideally in a 1.5T or 3.0T MR scanner. Arms should be placed above the patient’s head, or folded across the chest to prevent wrap artifact (also known as image aliasing artifact).

MR Pulse Sequences

Precontrast Sequences

Axial T1 Weighted Sequences: To survey the intra-abdominal structures, axial T1 weighted images are useful. These can be performed as breath-hold in and out of phase sequences, or using a double inversion fast spin echo technique to eliminate signal from slowly flowing blood. Precontrast T1-weighted images are particularly important for evaluation of the aortic wall for possible pathologies, such as intramural hematoma, which may have high T1 signal related to the presence of hemorrhage. Axial T2 fast spin echo sequences (usually with fat suppression) can also be performed from the diaphragm to the iliac crests to evaluate mass lesions and fluid collections around grafts.

Steady-State Free Precession: Steady-state free precession sequences (also termed balanced-FFE, true-FISP, and FIESTA) are rapid, have high intrinsic contrast resolution, and have been shown to be accurate in evaluating renal artery stenosis,2 aneurysm sac contents (Figure 102-1),3 thoracic aortic dissection, and aneurysm.4 These sequences can be performed with breath-hold techniques or free breathing with navigator gating, and they provide an overview of the aneurysm sac and surrounding contents.

Velocity Encoded Cine MR Techniques: Unlike the thoracic aorta, velocity encoded cine MR techniques (also known as cine phase contrast MR) are not widely used in the abdominal aorta. However, in cases of abdominal aortic coarctation or stenosis, these techniques may assist in quantifying the hemodynamic severity of the obstruction.

Postcontrast MRA: Following contrast injection, the abdominal aorta is scanned using a 3D spoiled gradient echo pulse sequence. The sequence should be optimized to acquire a near isotropic voxel size of 1 to 1.5 mm, in approximately 10 to 15 seconds.

CONTRAST MEDIA

A bolus of intravenous gadolinium-chelate contrast agent for MRA, or of iodinated contrast agent for CTA, is typically injected through a peripheral vein followed by a saline flush. The aim of MRA or CTA of the abdominal aorta, as with MRA and CTA elsewhere in the body, is to achieve peak arterial enhancement during the critical imaging periods, which for CTA is during the whole helical acquisition, and for MRA, is during the acquisition of the central lines of k-space. Proper synchronization of imaging for the arterial transit of the bolus through the target vascular bed will ensure optimal arterial illustration.

The time that it takes for a contrast bolus to pass from the site of intravenous injection until it reaches the abdominal aorta varies widely between individuals, from as little as 10 seconds to as long as 60 seconds. Consequently, varying techniques are available to synchronize MR and CT acquisition with peak arterial enhancement.

Contrast Media Dose

For abdominal aortic CTA, doses of up to 150 mL of nonionic contrast delivered at 3 to 6 mL per second have been routinely used in the past. However, with rapid acquisition techniques, doses as low as 50 mLs have been used, especially in smaller patients.5 For MRA, a typical gadolinium-chelate contrast agent dose is 0.2 mmol/kg injected at 2 mL/sec.

ABDOMINAL AORTIC ANEURYSM

Abdominal aortic aneurysm (AAA) is enlargement of the abdominal aorta above a diameter of 3 cm.7

Prevalence and Epidemiology

Abdominal aortic aneurysms are nearly five times more common in men than in women and almost twice as common in people of European descent than African Americans. The prevalence of aneurysm is also increased in those with a family history of AAA, and is strongly related to a history of smoking.8 Other risk factors include age, coronary artery disease or another manifestation of atherosclerosis, high cholesterol, and hypertension. In a large ultrasound screening study,9 an abdominal aortic aneurysm was detected in approximately 5% of males older than 65 years. Ruptured AAA occurs in 1% to 3% of men per year aged 65 years or more, and mortality is 70% to 95%. Left untreated, AAA leads to death in about one third of patients.8

Etiology and Pathophysiology

Although the exact etiology of AAA remains unclear, it appears that degradation of elastin, collagen, and other structural proteins in the aortic wall is a major factor.10 Atherosclerosis is considered to play an important role in the etiology, likely via chronic inflammation in the aortic wall. An imbalance of T-helper and T-suppressor lymphocytes leads to a proliferation of B-lymphocytes. Elastin-derived peptides (EDPs), which are breakdown products of medial elastin, are thought to be the initiating and propagating antigen in this process. Chronic inflammation leads to excess matrix metalloproteinases and degradation of medial elastin and collagen.11 However, the etiology is unquestionably multifactorial. Current research suggests that genetic, environmental, hemodynamic, and immunologic factors all contribute to the development of aneurysms.

Imaging Indications and Algorithm

The U.S. Preventive Services Task Force (USPSTF)16 recommends screening for AAA in men aged 65 to 75 years of age who have ever smoked. It can also be considered in patients with a strong family history of AAA. Ultrasound is the modality of choice for screening in most patients. Its advantages include the absence of intravenous contrast, absence of ionizing radiation, and relatively low cost.

For asymptomatic and smaller aneurysms, ultrasound surveillance is recommended (Table 102-1). For aneurysms >4.5 cm, CT or MRI offer the advantages of greater measurement accuracy, better depiction of the suprarenal aorta and branch vessels, and superior reproducibility versus ultrasonography.

TABLE 102-1 Rescreening Intervals for Asymptomatic AAAs

Diameter up to Re-image aorta in
<3.5 cm 3 years
<4.0 cm 2 years
<4.5 cm 1 year
<5 cm 6 months
5-5.5 cm 3-6 months*

* Also consider referral to a vascular surgeon.

Derived from Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation 2005; 111(6):816-828.

Imaging Techniques and Findings

Ultrasonography

Examination of the abdominal aorta is an essential component of a complete abdominal ultrasound study, and should be examined in all patients presenting with acute abdominal pain. Abdominal aortic aneurysms should be detectable by sonography in up to 100% of patients.18

The aorta appears on ultrasound as a hypoechoic tubular structure with echogenic walls (Fig. 102-3A). The anterior and posterior walls of the aneurysm are usually better seen than are the lateral walls. Mural thrombus (see Fig. 102-3B) has low to medium echogenicity and is attached to the margins of the aortic wall. At times, mural thrombus will have a lamellated appearance. Thrombus that appears to “flutter” during the cardiac cycle may be at risk of embolization.

Ultrasound measurements of abdominal aortic aneurysms are accurate and repeatable. The measurements are taken from the outer-to-outer wall of the aorta in a plane perpendicular to the long axis of the aorta.

In suspected aneurysm rupture, a bedside ultrasonogram may be helpful for those patients who are too unstable for CT, or if CT is not readily available. Ultrasound scanning may assist in determining the aneurysm size and the presence of retroperitoneal or intraperitoneal fluid (Fig. 102-4), although the role of ultrasonography in identifying impending rupture is limited.19

CT and MRI

Compared to ultrasonography, CT and MRI (Fig. 102-5) provide superior depiction of the extent and shape of the aneurysm, involvement of the renal, mesenteric, and iliac arteries, and the suprarenal abdominal and thoracic aorta. On average, ultrasound underestimates aneurysm size by 3 to 9 mm compared to CT angiography.20 Due to their excellent contrast resolution and multiplanar capabilities, CT and MR angiography are now the mainstay of aneurysm characterization prior to endovascular or surgical repair. CT is the modality of choice for the evaluation of suspected rupture of the abdominal aorta19; usually it can be performed within minutes, and has clear benefits in showing alternative causes of acute abdominal pain. Contrast-enhanced CT provides information about the lumen size, location, extent, relationship to branch vessels, presence of active contrast extravasation, and complications secondary to aneurysm rupture.

Signs of Rupture, Impending Rupture, and Contained Rupture

Noncontrast CT is useful in demonstrating the presence of an abdominal aortic aneurysm, maximum aneurysm size, and the presence of retroperitoneal hemorrhage. A high attenuating crescent within the wall of aneurysm (Figs. 102-6 and 102-7) is a sign of impending or frank aneurysm rupture.21 A high attenuation crescent is denser than the psoas muscles (on enhanced CT) and the lumen (on nonenhanced CT scans).

The most common finding in aneurysm rupture is a retroperitoneal hematoma adjacent to the abdominal aortic aneurysm (see Figs. 102-4, 102-7, and 102-8). This blood usually tracks into the pararenal and perirenal spaces (Fig. 102-9). Active extravasation (Figs. 102-9 and 102-10) is frequently visualized on contrast-enhanced CT images. The “draped aorta sign,” where the abdominal aorta is closely applied to the spine with lateral “draping” of the aneurysm around the vertebral body (see Fig. 102-4), has been described as a finding of a deficient posterior wall of the aorta and a contained leak.22 Other sites of rupture include the bowel (most commonly the duodenum), and inferior vena cava (Fig. 102-11).23 Signs of AAA rupture, impending rupture, and contained rupture are (1) periaortic and retroperitoneal hemorrhage; (2) contrast extravasation; (3) high attenuating crescent sign; and (4) draped aorta sign.

FDG-PET

Recent evidence suggests that increased aortic wall metabolism, as measured by FDG-PET, may suggest increased rupture risk. Increased metabolism may represent increased activation of inflammatory cells in the aortic wall, which leads to increased degradation of elastin and collagen in the aneurysm wall.24 Pilot studies examining the role of FDG-PET-CT in asymptomatic and symptomatic AAAs,25 have demonstrated increased activity in those with symptomatic AAAs, and increased activity in focal areas of increased inflammation and collagen degradation.

INFLAMMATORY AORTIC ANEURYSM

A variant of aortic aneurysm, inflammatory abdominal aortic aneurysms (IAAAs) are characterized by peri-aneurysmal fibrosis and adhesions and are a surgical challenge. Surgical repair is associated with a higher morbidity and mortality than surgery for degenerative AAAs.

Imaging Techniques and Findings

CT and MRI

MDCT and MRI are the mainstays in the investigation of suspected inflammatory abdominal aortic aneurysms. CT accurately distinguishes IAAA from AAA in 93.7% of cases.30 Signs include a thickened, calcified aortic wall surrounded by a low density soft tissue mass (Figs. 102-12 and 102-13). There is relative sparing of the posterior wall of the aorta. The inflammatory soft tissue surrounding the aorta undergoes contrast enhancement in both CT and MRI (Fig. 102-14). On CT, periaortic inflammatory soft tissue generally has lower density than acute blood, helping differentiation from acute AAA rupture. CT and MRI are useful to assess associated effects on adjacent structures, such as ureteric encasement, hydronephrosis, inferior vena cava narrowing, and bowel involvement. Ureteric involvement is present in approximately 25% of cases (see Fig. 102-13) at presentation.11

Treatment Options

MYCOTIC AORTIC ANEURYSM

Mycotic aortic aneurysms (also known as infected aortic aneurysms) represent a minority of AAAs. Their diagnosis may be difficult. They have a higher incidence of rupture and are challenging to treat. Perioperative morbidity and mortality is also higher than in noninfected AAAs.

Prevalence and Epidemiology

Mycotic AAAs are rare, representing 0.7% to 2.6% of all aortic aneurysms.33 They are associated with immunosuppression and chronic comorbid conditions, such as diabetes or renal failure.34

Imaging Findings

The imaging findings of mycotic aneurysms are similar across all modalities including ultrasound, CT scan, MRI, and angiography.

Treatment Options

Medical

Parenteral antimicrobial therapy is mandatory in all mycotic aneurysms. Patients are treated for at least 6 weeks and until inflammatory markers normalize.35 Some suggest treating patients with antibiotics for life.36 Initial treatment is empiric. After microorganism susceptibility testing has been performed, more specific agents can be started.

Surgical/Interventional

In cases of suprarenal mycotic aortic aneurysms, in situ repair or reconstruction is the preferred surgery.37 In-situ bypass reconstruction is the procedure of choice in infected infrarenal aortic aneurysms. Critically ill patients who cannot tolerate surgery can be treated with endovascular repair until definitive intervention can be performed.38,39

COMPLICATIONS OF ENDOVASCULAR AORTIC ANEURYSM REPAIR

Major complications from endovascular aortic aneurysm repair occur in approximately 5% of cases. Endoleak, or contrast enhancement of the aneurysm sac following endovascular aortic aneurysm repair (EVAR) is much more common and occurs in 30% to 40% of patients acutely and in 20% to 40% during routine follow-up. Endoleaks are defined as blood flow within the aortic sac, but outside the stent graft lumen. A “primary endoleak” occurs within 30 days of implantation, and a “secondary endoleak” occurs after 30 days.

Etiology and Pathophysiology

Endoleaks are classified according to the site and cause of the leak (Table 102-2). Deficient sealing at the proximal or distal end of the stent graft causes type I endoleaks. Primary type I endoleaks are usually caused by difficult anatomy (e.g., angulated aneurysm neck), a noncircular landing zone, malpositioning, or underdilation of the stent graft. Secondary type I leaks may be caused by aneurysm remodeling, stent graft migration, or progressive dilation of the neck.41 Systemic blood pressure occurs within the aortic sac in type 1 endoleaks, and there is persistent tension on the aortic wall.

TABLE 102-2 Classification of Endoleaks

I

II

III IV Graft-wall porosity V Endotension

Adapted from Golzarian J, Valenti D. Endoleakage after endovascular treatment of abdominal aortic aneurysms: Diagnosis, significance and treatment. Eur Radiol 2006; 16(12):2849-2857.

Type II endoleaks are due to retrograde filling of the aneurysm sac from branch arteries, usually the lumbar arteries or inferior mesenteric artery (Fig. 102-16). About 40% of type II endoleaks will seal spontaneously, and the risk of aneurysm expansion and rupture with type II endoleaks is lower than with types I or III.

Type III endoleaks are caused by a failure in the structure of the graft: junctional separation of the modular components of the graft, holes in the fabric, and tears due to strut failure. As in type I endoleaks, the aneurysm sac is exposed to full systemic pressure in type III endoleaks, and hence, intervention is usually necessary.

Type IV endoleaks are due to graft fabric porosity. These may be seen temporarily at the time of endograft placement.

Type V endoleak, also known as endotension, is continuing expansion of the aneurysm in the absence of a confirmed endoleak. Endotension may be due to an undiagnosed endoleak or due to the accumulation of serous fluid in the sac due to ultra-filtration through the graft pores.

Imaging Indications and Algorithm

Due to the absence of long-term clinical data on stent-graft performance, it is generally accepted that life-long imaging surveillance is necessary.42 However, the ideal surveillance strategy has been widely debated. The Society of Interventional Radiology Device Forum,43 recommends four views of the abdomen (AP, lateral, and oblique) performed after placement of the graft, and every 6 months for at least 2 years. In addition, imaging with CTA, MRI, or ultrasound should be considered at baseline. If no complications are present, surveillance should be repeated every 6 months for 2 years, and then yearly.43 Some investigators42,44 have used AP and lateral radiographs and CTA at less frequent intervals.

Imaging Techniques and Findings

Radiography

Radiography plays a useful role in the evaluation for stent graft expansion; migration, kinking, dislocation, and hook or tent fracture can be identified.45 Although multiplanar reformations on CT allow characterization of many of these complications, plain radiographs have the advantage because they are less susceptible to artifact from metallic prostheses.

Stent migration usually involves caudal migration of the proximal end, whereas the distal end of the stent is more likely to move cranially. Care should be taken to avoid parallax error when assessing for migration.45 Kinking or deformity of the stent often accompanies migration.

TRAUMATIC ABDOMINAL AORTIC INJURY

ACUTE AORTIC OCCLUSION

Acute occlusion of the abdominal aorta is a vascular emergency, usually resulting from a saddle embolus or thrombosis. It has a high mortality rate (75%) with conservative treatment.51

Clinical Manifestations of Disease

The absence of both femoral pulses in a patient without significant atherosclerosis risk factors is highly suggestive of the diagnosis.49 Patients may present with paralysis mimicking acute spinal cord compression, and a subsequent delay in diagnosis may increase mortality. Coexistent cardiac arrhythmias suggest a saddle embolus.

Imaging Indications and Algorithm

When acute aortic occlusion is suspected, CT is the most appropriate imaging modality given its wide availability and quick acquisition. If iodinated contrast is contraindicated (contrast allergy), MRI and ultrasound (Fig. 102-19) can also be used.

TAKAYASU ARTERITIS

Takayasu arteritis (TA), also known as nonspecific aortitis, is a chronic inflammatory disorder that affects the aorta, branch vessels, and the pulmonary arteries. Progressive vascular occlusion with systemic ischemic symptoms usually ensue.

Imaging Indications and Algorithm

GIANT CELL ARTERITIS (TEMPORAL ARTERITIS)

Giant cell arteritis is the most common idiopathic vasculitis of the large- and medium-sized arteries. It classically affects the temporal artery and other cranial vessels, although the aorta may be affected.

Etiology and Pathophysiology

Alhough both the humoral and cellular immune system are involved in the pathogenesis of giant cell arteritis, cell-mediated processes are paramount.61 The initial activating factor is unknown; autoantigens, infectious agents, and toxins have been implicated. Transmural inflammation of the arteries results in eventual luminal occlusion through intimal hyperplasia of branch vessels of the aorta. However, in the aorta, inflammation results in aneurysm formation, dissection, and rupture.

Imaging Techniques and Findings

AORTOENTERIC FISTULAS

Abdominal aortoenteric fistulas (AEF) are direct communications between the abdominal aorta and the gastrointestinal tract.

Prevalence and Epidemiology

Approximately 80% of aortoenteric fistulas arise in the duodenum, and about 60% of these arise in the third part.66 Outside the duodenum, the jejunum, sigmoid colon, stomach, and ileum can be involved. Aorta-duodenal fistulas following surgical repair of a prior aortic aneurysm (secondary) are more common than de novo aorta-duodenal fistulas from an abdominal aortic aneurysm (primary). Aorta-duodenal fistulas occur approximately 0.4% to 2.4% of the time following aortic aneurysm surgery. They can manifest soon after surgery or years later.

ABDOMINAL AORTIC DISSECTION

Abdominal aortic dissection consists of an entry tear in the inner layers of the wall of the abdominal aorta, allowing blood to flow between the mural layers. Spontaneous abdominal aortic dissections not associated with thoracic aortic dissection are extremely rare, representing approximately 2% of all aortic dissections.

In a review of the literature by Farber and colleagues,70 about 40% of spontaneous abdominal aortic dissections were associated with AAA. Abdominal aortic dissection may be the result of atheromatous disease; conversely, the dissection may cause aneurysm formation due to a weakened wall. Abdominal aortic dissections generally originate at or below the level of the renal arteries (Fig. 102-25).

They may be iatrogenic (e.g., as a complication of vascular catheterization), traumatic, or spontaneous. Like thoracic dissection, isolated aortic dissection is associated with hypertension.71 Marfan syndrome has not been associated with abdominal aortic dissection. Patients usually present with back pain, peripheral ischemia, and signs of distal embolization but may be asymptomatic. A pulsatile abdominal mass is usually present.

Because of its low incidence, the natural history is unknown, although rupture has been reported in up to 25% of patients in one study.70 In uncomplicated cases, medical management typically consists of blood pressure control and vasodilators. Treatment may include open or endovascular repair in patients with major aortic branch occlusion, aortic expansion, extension of the dissection, and aortic rupture.

KEY POINTS

REFERENCES

1 Kalva SP, et al. Using the K-edge to improve contrast conspicuity and to lower radiation dose with a 16-MDCT: a phantom and human study. J Comput Assist Tomogr. 2006;30(3):391-397.

2 Maki JH, et al. Steady-state free precession MRA of the renal arteries: breath-hold and navigator-gated techniques vs. CE-MRA. J Magn Reson Imaging. 2007;26(4):966-973.

3 Schwope RB, et al. MR angiography for patient surveillance after endovascular repair of abdominal aortic aneurysms. AJR Am J Roentgenol. 2007;188(4):W334-W340.

4 Pereles FS, et al. Thoracic aortic dissection and aneurysm: evaluation with nonenhanced true FISP MR angiography in less than 4 minutes. Radiology. 2002;223(1):270-274.

5 Cohen EI, et al. Time-resolved MR angiography for the classification of endoleaks after endovascular aneurysm repair. J Magn Reson Imaging. 2008;27(3):500-503.

6 Kubo S, et al. Thoracoabdominal-aortoiliac MDCT angiography using reduced dose of contrast material. AJR Am J Roentgenol. 2006;187(2):548-554.

7 Johnston KW, et al. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1991;13(3):452-458.

8 Lederle FA, et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med. 1997;126(6):441-449.

9 Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial. BMJ. 2002;325(7373):1135.

10 Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation. 2005;111(6):816-828.

11 Tang T, et al. Inflammatory abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2005;29(4):353-362.

12 Brown PM, et al. Selective management of abdominal aortic aneurysms in a prospective measurement program. J Vasc Surg. 1996;23(2):213-220.

13 Hallin A, Bergqvist D, Holmberg L. Literature review of surgical management of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2001;22(3):197-204.

14 Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet. 1998;352(9141):1649-1655.

15 Siegel CL, et al. Abdominal aortic aneurysm morphology: CT features in patients with ruptured and nonruptured aneurysms. AJR Am J Roentgenol. 1994;163(5):1123-1129.

16 U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med. 2005;142(3):198-202.

17 Julius Grollman, M.A.B., Thomas Casciani, Antoinette S. Expert Panel on Vascular Imaging: Gomes, Stephen R. Holtzman, Joseph F. Polak, David Sacks, William Stanford, Michael Jaff, Gregory L. Moneta. American College of Radiology ACR Appropriateness Criteria: Pulsatile Abdominal Mass. 2005 2005 [cited 2008 December 2, 2008]; Available from http://www.acr.org/SecondaryMainMenuCategories/quality_safety/app_criteria/pdf/Vascular/PulsatileAbdominalMassDoc13.aspx

18 Rumack CM, Wilson SR, Charboneau JW. Diagnostic Ultrasound, 3rd ed. St. Louis: Elsevier Mosby; 2005. 2 v. (xxiv, 2080, xxxiv)

19 Rakita D, et al. Spectrum of CT findings in rupture and impending rupture of abdominal aortic aneurysms. Radiographics. 2007;27(2):497-507.

20 Sprouse LR2nd, et al. Comparison of abdominal aortic aneurysm diameter measurements obtained with ultrasound and computed tomography: Is there a difference? J Vasc Surg. 2003;38(3):466-471.

21 Mehard WB, Heiken JP, Sicard GA. High-attenuating crescent in abdominal aortic aneurysm wall at CT: a sign of acute or impending rupture. Radiology. 1994;192(2):359-362.

22 Halliday KE, al-Kutoubi A. Draped aorta: CT sign of contained leak of aortic aneurysms. Radiology. 1996;199(1):41-43.

23 Schwartz SA, et al. CT findings of rupture, impending rupture, and contained rupture of abdominal aortic aneurysms. AJR Am J Roentgenol. 2007;188(1):W57-W62.

24 Sakalihasan N, Hustinx R, Limet R. Contribution of PET scanning to the evaluation of abdominal aortic aneurysm. Semin Vasc Surg. 2004;17(2):144-153.

25 Reeps C, et al. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg. 2008;48(2):417-423.

26 Powell JT, Greenhalgh RM. Clinical practice. Small abdominal aortic aneurysms. N Engl J Med. 2003;348(19):1895-1901.

27 Wilmink TB, Quick CR, Day NE. The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg. 1999;30(6):1099-1105.

28 Gadowski GR, Pilcher DB, Ricci MA. Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg. 1994;19(4):727-731.

29 Cullenward MJ, et al. Inflammatory aortic aneurysm (periaortic fibrosis): radiologic imaging. Radiology. 1986;159(1):75-82.

30 Iino M, et al. Sensitivity and specificity of CT in the diagnosis of inflammatory abdominal aortic aneurysms. J Comput Assist Tomogr. 2002;26(6):1006-1012.

31 Hellmann DB, Grand DJ, Freischlag JA. Inflammatory abdominal aortic aneurysm. JAMA. 2007;297(4):395-400.

32 Puchner S, et al. Endovascular therapy of inflammatory aortic aneurysms: a meta-analysis. J Endovasc Ther. 2005;12(5):560-567.

33 Macedo TA, et al. Infected aortic aneurysms: imaging findings. Radiology. 2004;231(1):250-257.

34 Oderich GS, et al. Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg. 2001;34(5):900-908.

35 Cina CS, et al. Ruptured mycotic thoracoabdominal aortic aneurysms: a report of three cases and a systematic review. J Vasc Surg. 2001;33(4):861-867.

36 Katz SG, Andros G, Kohl RD. Salmonella infections of the abdominal aorta. Surg Gynecol Obstet. 1992;175(2):102-106.

37 Chan FY, et al. In situ prosthetic graft replacement for mycotic aneurysm of the aorta. Ann Thorac Surg. 1989;47(2):193-203.

38 Corso JE, Kasirajan K, Milner R. Endovascular management of ruptured, mycotic abdominal aortic aneurysm. Am Surg. 2005;71(6):515-517.

39 Koeppel TA, et al. Mycotic aneurysm of the abdominal aorta with retroperitoneal abscess: successful endovascular repair. J Vasc Surg. 2004;40(1):164-166.

40 Schurink GW, Aarts NJ, van Bockel JH. Endoleak after stent-graft treatment of abdominal aortic aneurysm: a meta-analysis of clinical studies. Br J Surg. 1999;86(5):581-587.

41 Golzarian J, Valenti D. Endoleakage after endovascular treatment of abdominal aortic aneurysms: diagnosis, significance and treatment. Eur Radiol. 2006;16(12):2849-2857.

42 Stavropoulos SW, Charagundla SR. Imaging techniques for detection and management of endoleaks after endovascular aortic aneurysm repair. Radiology. 2007;243(3):641-655.

43 Geller SC. Imaging guidelines for abdominal aortic aneurysm repair with endovascular stent grafts. J Vasc Interv Radiol. 2003;14(9 Pt 2):S263-S264.

44 Manning BJ, O’Neill SM, Haider SN, et al. Duplex ultrasound in aneurysm surveillance following endovascular aneurysm repair: a comparison with computed tomography aortography. J Vasc Surg. 2008;49(1):60-65.

45 Fearn S, et al. Follow-up after endovascular aortic aneurysm repair: the plain radiograph has an essential role in surveillance. J Endovasc Ther. 2003;10(5):894-901.

46 Kougias P, et al. Successful treatment of endotension and aneurysm sac enlargement with endovascular stent graft reinforcement. J Vasc Surg. 2007;46(1):124-127.

47 Veith FJ, et al. Nature and significance of endoleaks and endotension: summary of opinions expressed at an international conference. J Vasc Surg. 2002;35(5):1029-1035.

48 Roth SM, et al. Blunt injury of the abdominal aorta: a review. J Trauma. 1997;42(4):748-755.

49 Bhalla S, Menias CO, Heiken JP. CT of acute abdominal aortic disorders. Radiol Clin North Am. 2003;41(6):1153-1169.

50 Gunn M, Campbell M, Hoffer EK. Traumatic abdominal aortic injury treated by endovascular stent placement. Emerg Radiol. 2007;13(6):329-331.

51 Surowiec SM, et al. Acute occlusion of the abdominal aorta. Am J Surg. 1998;176(2):193-197.

52 Maffei S, et al. Takayasu’s arteritis: a review of the literature. Intern Emerg Med. 2006;1(2):105-112.

53 Maksimowicz-McKinnon K, Hoffman GS. Takayasu arteritis: what is the long-term prognosis? Rheum Dis Clin North Am. 2007;33(4):777-786. vi

54 Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129-1134.

55 Schmidt WA, Gromnica-Ihle E. What is the best approach to diagnosing large-vessel vasculitis? Best Pract Res Clin Rheumatol. 2005;19(2):223-242.

56 Gotway MB, et al. Imaging findings in Takayasu’s arteritis. AJR Am J Roentgenol. 2005;184(6):1945-1950.

57 Kobayashi Y, et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005;46(6):917-922.

58 Walter MA. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis. Radiol Clin North Am. 2007;45(4):735-744. viii

59 Kerr GS. Takayasu’s arteritis. Rheum Dis Clin North Am. 1995;21(4):1041-1058.

60 Anchishkin AI, Khodyreva V, Kurilov EN. [An organizational model for the activities of microbiology laboratories]. Zh Mikrobiol Epidemiol Immunobiol. 1991;5:79.

61 Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med. 2003;349(2):160-169.

62 Agard C, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59(5):670-676.

63 Narvaez J, et al. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford). 2005;44(4):479-483.

64 Blockmans D, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford). 2008;47(8):1179-1184.

65 Baril DT, et al. Endovascular treatment of complicated aortic aneurysms in patients with underlying arteriopathies. Ann Vasc Surg. 2006;20(4):464-471.

66 Lemos DW, et al. Primary aortoduodenal fistula: a case report and review of the literature. J Vasc Surg. 2003;37(3):686-689.

67 Low RN, et al. Aortoenteric fistula and perigraft infection: evaluation with CT. Radiology. 1990;175(1):157-162.

68 Hagspiel KD, et al. Diagnosis of aortoenteric fistulas with CT angiography. J Vasc Interv Radiol. 2007;18(4):497-504.

69 Saers SJ, Scheltinga MR. Primary aortoenteric fistula. Br J Surg. 2005;92(2):143-152.

70 Farber A, et al. Spontaneous infrarenal abdominal aortic dissection presenting as claudication: case report and review of the literature. Ann Vasc Surg. 2004;18(1):4-10.

71 Trimarchi S, et al. Acute abdominal aortic dissection: insight from the International Registry of Acute Aortic Dissection (IRAD). J Vasc Surg. 2007;46(5):913-919.